About: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.29 (+0.39%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
MAIANYSEMAIA Biotechnology Inc.
Loading watchlist status…
MAIA Biotechnology Inc. share price
MAIA price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
MAIA price performance
0%
5D
0%
1M
-16.34%
YTD
-15.79%
1Y
MAIA price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NYSE rank
N/ASector Rank
N/AMAIA details
MAIA Market Signals